Annoucements Archives | Page 2 of 2

Dermaxon receives grant from the National Institute of Neurological Disorders and Stroke

September 2019: DermaXon received a Phase 1 STTR Grant funding from the National Institute of Neurological Disorders and Stroke to support preclinical efficacy studies for a novel drug treatment for pruritus. This award, titled “TOPICAL SELECTIVE T-TYPE BLOCKERS FOR...

DermaXon LLC awarded grant for continued development of DX308 drug candidate for the treatment of Ichthyosis

MiSSOULA, Montana, Nov. 20, 2018 – DermaXon was been awarded a research grant from The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to further research treatment options for Ichthyosis.

Dermaxon receives grant from the National Institute of Neurological Disorders and Stroke

June 2018: DermaXon received a Phase 1 STTR Grant funding from the National Institute of Neurological Disorders and Stroke to support preclinical efficacy studies for a novel drug treatment for pain. This award titled “Topical selective T-type blockers for the...